Abstract
Pediatric autoimmune epileptic encephalopathies are predominantly characterized by the presence of autoantibodies to the surface of neuronal proteins, for example, N-methyl-d-aspartate (NMDA) receptor antibodies, but also include diseases with non-cell surface antibodies (eg, anti-Hu, glutamic-acid decarboxylase antibodies). In some cases with distinct clinical and para-clinical features, an autoimmune epileptic encephalopathy can be diagnosed without the presence of an antibody and will also respond favorably to immunotherapy. In this review, we summarize the common presentations of pediatric autoimmune epileptic encephalopathies, treatments, and outcomes, and report recent findings in the field of epilepsy, encephalopathy, and the immune system.
| Original language | English |
|---|---|
| Pages (from-to) | 418-428 |
| Number of pages | 11 |
| Journal | Journal of Child Neurology |
| Volume | 32 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 1 Mar 2017 |
Funding
SW was funded by an Oxford University/Wellcome Trust Clinical Research Training Fellowship HMRVOW0. Work in the Oxford laboratory is partly supported by the NIHR Oxford Biomedical Research Centre.
Keywords
- autoantibodies
- autoimmune epilepsy
- encephalopathy
- NMDA receptor antibody encephalitis
- voltage-gated potassium channel complex
Fingerprint
Dive into the research topics of 'Pediatric Autoimmune Epileptic Encephalopathies'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver